STOCK TITAN

Medline's Amanda H. Laabs converts 820,000 units

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Medline Inc. Chief Product Officer Amanda H. Laabs reported converting 820,000 fully vested Incentive Units into 820,000 Common Units on November 12, 2026; the Incentive Units had a $15.09 per-unit participation threshold. The Common Units are held indirectly through Medline Management Aggregator LLC and are exchangeable one-for-one for Class A Common Stock. In connection with the exchange, 299,873 Common Units were reported as delivered or withheld for payment of exercise price or tax liability; a footnote describes them as deemed withheld in connection with the exchange. Laabs acquired 520,127 Class B shares, bringing her direct Class B holdings to 771,197; reported Incentive Unit holdings following the transaction were 422,391.

Insider Laabs Amanda H.
Role Chief Product Officer
Type Security Shares Price Value
Exercise Incentive Units of Medline Holdings, LP F1, F2, F3 820,000 -- --
Exercise Common Units of Medline Holdings, LP F4, F1, F2 820,000 $15.09 $12.37M
Exercise Price or Tax Liability Common Units of Medline Holdings, LP F4, F6, F1, F2 299,873 $26.67 $8.00M
Grant/Award Class B Common Stock F1, F2, F5 520,127 -- --
Holdings After Transaction: Incentive Units of Medline Holdings, LP — 422,391 units (Indirect, See Footnote); Common Units of Medline Holdings, LP — 771,197 units (Indirect, See Footnote); Class B Common Stock — 771,197 shares (Direct)
Footnotes (6)
  1. F1. Reflect incentive units of Medline Holdings, LP ("Incentive Units"), which are "profit interests" having economic characteristics similar to stock appreciation rights. Vested Incentive Units are convertible, at the holder's election, into a number of common units of Medline Holdings, LP ("Common Units") generally equal to (a) the product of the number of vested Incentive Units to be converted with a given per unit participation threshold and then-current difference between the per unit value of a Common Unit at the time of the conversion (based on the public trading price of a share of Medline Inc.'s (the "Issuer") Class A common stock ("Class A Common Stock")) and the per unit participation threshold of such vested Incentive Units divided by (b) the per unit value of a Common Unit at the time of the conversion (based on the public trading price of a share of Class A Common Stock), subject to certain adjustments.
  2. F2. (Continued from Footnote 1 above) Common Units are exchangeable on a one-for-one basis for shares of Class A Common Stock pursuant to the terms of the exchange agreement, dated as of December 16, 2025 (the "Exchange Agreement"). These Incentive Units have no expiration date. Such Incentive Units are held indirectly through Medline Management Aggregator LLC. In connection with the conversion of Incentive Units into Common Units, upon issuance of Common Units, an equivalent number of shares of Class B common stock ("Class B Common Stock") are automatically issued.
  3. F3. These Incentive Units are fully vested.
  4. F4. Pursuant to the terms of the Exchange Agreement, holders have the right to exchange their Common Units for shares of Class A Common Stock on a one-for-one basis, subject to customary conversion rate adjustments for stock splits, stock dividends and reclassifications. These exchange rights do not expire. Such Common Units are held indirectly through Medline Management Aggregator LLC.
  5. F5. Shares of the Issuer's Class B Common Stock have no economic value and have one vote per share. One share of Class B Common Stock is issued for each Common Unit held. Upon the exchange of Common Units for shares of Class A Common Stock, an equivalent number of shares of Class B Common Stock are automatically cancelled.
  6. F6. Reflects Common Units deemed to be withheld in connection with the exchange of Incentive Units described herein.
Incentive Units converted 820,000 units November 12, 2026; fully vested units
Participation threshold $15.09 per unit Incentive Units converted on November 12, 2026
Common Units acquired 820,000 units November 12, 2026; held indirectly through Medline Management Aggregator LLC
Common Units delivered or withheld 299,873 units Reported for payment of exercise price or tax liability; footnote describes them as deemed withheld in connection with the exchange on November 12, 2026
Reported price per share $26.67 per share Code F transaction involving 299,873 Common Units on November 12, 2026
Class B shares acquired 520,127 shares November 12, 2026; held directly
Class B shares following transaction 771,197 shares Direct holdings following the November 12, 2026 transaction
Incentive Units following transaction 422,391 units Reported holdings following the November 12, 2026 transaction
profit interests financial
"profit interests having economic characteristics similar to stock appreciation rights"
participation threshold financial
"per unit participation threshold"
stock appreciation rights financial
"economic characteristics similar to stock appreciation rights"
Stock appreciation rights (SARs) are a form of employee compensation that give the holder the right to receive the increase in a company's stock price over a set baseline, paid in cash or shares, without having to buy the stock. For investors, SARs matter because they can create future cash outflows or share dilution and signal how a company rewards and motivates executives — similar to giving a bonus tied directly to how well the company’s stock performs.
exchangeable on a one-for-one basis technical
"Common Units are exchangeable on a one-for-one basis for shares of Class A Common Stock"
Class B Common Stock technical
"Class B Common Stock have no economic value and have one vote per share"
A class B common stock is one of multiple types of a company’s ordinary shares that carries specific rights—often different voting power or dividend priority—compared with other classes. For investors it matters because those differences affect how much influence you have over company decisions, the income you might receive, and how freely the shares trade; think of it like owning a car with different keys: some keys let you start the engine and open the trunk, others only unlock the door.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What transactions did Medline (MDLN) Chief Product Officer Amanda H. Laabs report?

On November 12, 2026, Laabs reported converting 820,000 fully vested Incentive Units into 820,000 Common Units, with a $15.09 per-unit participation threshold, and acquiring 520,127 Class B shares, bringing direct Class B holdings to 771,197. The report also lists 299,873 Common Units delivered or withheld for payment of exercise price or tax liability; a footnote says they were deemed withheld in connection with the exchange. Reported Incentive Unit holdings following the transaction were 422,391.

How can Medline Holdings Common Units be exchanged for MDLN Class A shares?

Common Units are exchangeable for Class A Common Stock on a one-for-one basis under the Exchange Agreement. The exchange rights do not expire and are subject to customary conversion-rate adjustments for stock splits, stock dividends and reclassifications.

What are Medline Class B shares' voting and economic rights?

Class B Common Stock has no economic value and one vote per share. One Class B share is issued for each Common Unit held, and an equivalent number of Class B shares is automatically cancelled when Common Units are exchanged for Class A shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Laabs Amanda H.

(Last)(First)(Middle)
C/O MEDLINE INC.
3 LAKES DRIVE

(Street)
NORTHFIELD ILLINOIS 60093

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Medline Inc. [ MDLN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Product Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/12/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class B Common Stock11/12/2026A520,127A(1)(2)(5)771,197D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Incentive Units of Medline Holdings, LP$15.09(1)(2)11/12/2026M820,000 (1)(2)(3) (1)(2)(3)Class A Common Stock(1)820,000(1)(2)422,391ISee Footnote(1)(2)
Common Units of Medline Holdings, LP(4)11/12/2026M820,000 (4) (4)Class A Common Stock820,000$15.09(1)(2)1,071,070ISee Footnote(4)
Common Units of Medline Holdings, LP(4)11/12/2026F(6)299,873 (4) (4)Class A Common Stock299,873$26.67(1)(2)771,197ISee Footnote(4)
Explanation of Responses:
1. Reflect incentive units of Medline Holdings, LP ("Incentive Units"), which are "profit interests" having economic characteristics similar to stock appreciation rights. Vested Incentive Units are convertible, at the holder's election, into a number of common units of Medline Holdings, LP ("Common Units") generally equal to (a) the product of the number of vested Incentive Units to be converted with a given per unit participation threshold and then-current difference between the per unit value of a Common Unit at the time of the conversion (based on the public trading price of a share of Medline Inc.'s (the "Issuer") Class A common stock ("Class A Common Stock")) and the per unit participation threshold of such vested Incentive Units divided by (b) the per unit value of a Common Unit at the time of the conversion (based on the public trading price of a share of Class A Common Stock), subject to certain adjustments.
2. (Continued from Footnote 1 above) Common Units are exchangeable on a one-for-one basis for shares of Class A Common Stock pursuant to the terms of the exchange agreement, dated as of December 16, 2025 (the "Exchange Agreement"). These Incentive Units have no expiration date. Such Incentive Units are held indirectly through Medline Management Aggregator LLC. In connection with the conversion of Incentive Units into Common Units, upon issuance of Common Units, an equivalent number of shares of Class B common stock ("Class B Common Stock") are automatically issued.
3. These Incentive Units are fully vested.
4. Pursuant to the terms of the Exchange Agreement, holders have the right to exchange their Common Units for shares of Class A Common Stock on a one-for-one basis, subject to customary conversion rate adjustments for stock splits, stock dividends and reclassifications. These exchange rights do not expire. Such Common Units are held indirectly through Medline Management Aggregator LLC.
5. Shares of the Issuer's Class B Common Stock have no economic value and have one vote per share. One share of Class B Common Stock is issued for each Common Unit held. Upon the exchange of Common Units for shares of Class A Common Stock, an equivalent number of shares of Class B Common Stock are automatically cancelled.
6. Reflects Common Units deemed to be withheld in connection with the exchange of Incentive Units described herein.
/s/ Nicole Fritz, Attorney-in-Fact11/16/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading